Literature DB >> 3713436

Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: similarities in rates and involvement of aminopeptidases.

S D Kashi, V H Lee.   

Abstract

The systemic delivery of peptides and proteins from the nasal, rectal, vaginal, and buccal mucosae has been the subject of active investigation. The objective of this study was to determine the pathway and rate of hydrolysis of methionine enkephalin (TGGPM), leucine enkephalin (TGGPL), and [D-Ala2] met-enkephalinamide (TAGPM) in homogenates of these non-oral mucosae relative to the ileal mucosa. Aminopeptidases appeared to contribute over 85% to the hydrolysis of TGGPM and TGGPL, while dipeptidyl peptidase and dipeptidyl carboxypeptidase contributed much less. Overall, TGGPM was somewhat more susceptible to hydrolysis than TGGPL but was 10 times more so than TAGPM. These enkephalins were most rapidly hydrolyzed in the rectal and buccal homogenates, followed by the nasal and then the vaginal homogenates, but the differences in hydrolytic rates were small. Indeed, these rates did not differ substantially from the ileal mucosa, suggesting that the same enzymatic barrier to enkephalin absorption possibly exists in both the oral and the non-oral mucosae.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713436     DOI: 10.1016/0024-3205(86)90150-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

1.  A comparison of peptidase activities and peptide metabolism in cultured mouse keratinocytes and neonatal mouse epidermis.

Authors:  P K Shah; R T Borchardt
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

2.  Intranasal delivery--modification of drug metabolism and brain disposition.

Authors:  Yin Cheong Wong; Zhong Zuo
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 3.  Drug metabolism in the nasal mucosa.

Authors:  M A Sarkar
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

4.  Development of novel lipophilic derivatives of DADLE (leucine enkephalin analogue): intestinal permeability characateristics of DADLE derivatives in rats.

Authors:  T Uchiyama; A Kotani; H Tatsumi; T Kishida; A Okamoto; N Okada; M Murakami; T Fujita; Y Fujiwara; Y Kiso; S Muranishi; A Yamamoto
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

Review 5.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

6.  Oral absorption of peptides: the effect of absorption site and enzyme inhibition on the systemic availability of metkephamid.

Authors:  P Langguth; H P Merkle; G L Amidon
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

7.  Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.

Authors:  D I Friedman; G L Amidon
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

8.  Transport and hydrolysis of enkephalins in cultured alveolar epithelial monolayers.

Authors:  L Wang; D Toledo-Velasquez; D Schwegler-Berry; J K Ma; Y Rojanasakul
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

9.  Transdermal delivery of bioactive peptides: the effect of n-decylmethyl sulfoxide, pH, and inhibitors on enkephalin metabolism and transport.

Authors:  H K Choi; G L Flynn; G L Amidon
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

10.  The effect of cyclodextrins on the stability of peptides in nasal enzymic systems.

Authors:  W J Irwin; A K Dwivedi; P A Holbrook; M J Dey
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.